$TER

MATZ MARILYN sold $428K of TER

MATZ MARILYN sold 1,200 shares of TERADYNE, INC (TER) at $356.31 ($0.43M total) on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MATZ MARILYN
Published Jul 16, 2026, 5:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price ($356.31/share), and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 structure and lack of additional fundamental information suggest limited trading edge.

03

What to watch

The article does not state whether the director’s sale was part of a larger series, nor does it provide context on total holdings changes beyond the post-transaction share count.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-16, covering a sale executed 2026-07-15.

Background

The article is a SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne director MatZ Marilyn sold 1,200 shares in an open-market transaction on 2026-07-15 under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal impact on TER price; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction, but it specifies an open-market sale and a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector read-across is provided; this is company-specific insider activity only.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with management’s view of valuation or liquidity needs, which some traders may still treat as mildly bearish.

Key entities

  • TERADYNE, INC

    Company whose director disclosed an open-market sale of shares via Form 4.

  • MATZ MARILYN

    Director who sold 1,200 shares on 2026-07-15 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMHighAI 8/10

FormFactor and Teradyne announce collaboration, $300M investment

FormFactor (FORM) and Teradyne (TER) announced a collaboration and $300M investment in semiconductor test and measurement technologies. The deal aims to combine FormFactor's probe technologies with Teradyne's automated test platforms, focusing on high-performance compute and advanced packaging applications. The transaction is subject to regulatory approvals.